Amniotic membrane transplantation combined with cryotherapy vs. lamellar keratoplasty for medically refractory peripheral ulcerative keratitis: a retrospective cohort study
Frontiers in Medicine · 12.06.2026 · 13
DOI: 10.3389/fmed.2026.1833378 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Medicine, online erschienen am 12.06.2026. Verfasst von Jia Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, General Hospital of Northern Theater Command, Shenyang, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Medically refractory peripheral ulcerative keratitis (PUK) is a severe condition requiring urgent surgery. This study compares the clinical outcomes of amniotic membrane transplantation (AMT) combined with cryotherapy vs. lamellar keratoplasty (LKP) for this high-risk group.
Methods
This retrospective cohort study evaluated patients with refractory PUK who underwent either AMT or LKP with a 12-month follow-up. Outcome measures included ulcer healing rate, best-corrected visual acuity (BCVA), epithelialization time, and recurrence rate.
Results
A total of 58 patients (58 eyes) were included (AMT: n = 28; LKP: n = 30). Primary ulcer healing rates were comparable between the groups (AMT: 78.6%, LKP: 76.7%; P = 0.862). Both groups showed similar BCVA improvements up to 6 months postoperatively. However, the LKP group demonstrated significantly faster epithelialization (median 6 vs. 12 days; P < 0.05), superior BCVA at 12 months ( P = 0.019), and a lower disease recurrence rate (10.0% vs. 32.1%; P = 0.038), although AMT demonstrated a superior safety profile with no procedure-related complications. Concurrent autoimmune diseases significantly prolonged epithelialization in both cohorts.
Conclusions
LKP provides superior long-term optical/structural restoration and a lower recurrence rate, making it the definitive treatment for refractory PUK. However, AMT matches LKP in primary healing and mid-term efficacy. Amid global donor shortages, AMT serves as an invaluable, safe bridging therapy to stabilize the ocular surface and manage acute inflammation before definitive keratoplasty.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, General Hospital of Northern Theater Command, Shenyang, China.
Zitieren
APA
Wan, J., Bao, J., Wang, C., Gao, R., Zhang, K., & Chen, Y. (2026). Amniotic membrane transplantation combined with cryotherapy vs. lamellar keratoplasty for medically refractory peripheral ulcerative keratitis: a retrospective cohort study. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1833378
Vancouver
Wan J, Bao J, Wang C, Gao R, Zhang K, Chen Y. Amniotic membrane transplantation combined with cryotherapy vs. lamellar keratoplasty for medically refractory peripheral ulcerative keratitis: a retrospective cohort study. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1833378
BibTeX
@article{Wan2026,
author = {Wan, Jia and Bao, Juan and Wang, Cuiyu and Gao, Ruiyao and Zhang, Kai and Chen, Yingxin},
title = {Amniotic membrane transplantation combined with cryotherapy vs. lamellar keratoplasty for medically refractory peripheral ulcerative keratitis: a retrospective cohort study},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1833378}
}
EUVIMED